ISRCTN47911040进行中（未招募）未知
Application of human umbilical cord-derived mesenchymal stem cells for moderate to severe acute respiratory distress syndrome: a randomized phase II clinical trial
Chang Gung Memorial Hospital0 个研究点目标入组 60 人开始时间: 2021年10月26日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Adult subjects aged 20-80 years with moderate to severe ARDS, defined as:
- •1.1. Acute onset
- •1.2. Bilateral infiltration on chest X-ray
- •1.3. Pulmonary wedge pressure =18 mmHg
- •1.4. PaO2/FiO2 =200 mmHg
- •1.5. PEEP =10 cm H2O
- •2. Symptoms don’t improve 5 days after traditional or standard therapy
排除标准
- •1. Age <20 or >80 years
- •2. Pregnancy, breastfeeding
- •3. Malignancy
- •4. Autoimmune disease
- •5. Subjects not suitable for enrollment due to any reason evaluated by the investigator, or patients who have joined other studies
研究者
相似试验
已完成
不适用
Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune ThrombocytopeniaMesenchymal Stem CellsThrombocytopeniaNCT04014166Institute of Hematology & Blood Diseases Hospital, China18
已完成
1 期
Human Umbilical Cord Mesenchymal Stem Cell Transplantation in Articular Cartilage DefectCartilage DiseasesOsteoarthritisNCT02291926Shenzhen Hornetcorn Bio-technology Company, LTD20
Unknown
1 期
Human Umbilical Cord-Mesenchymal Stem Cells for PneumoconiosisPneumoconiosisNCT02790762Shenzhen Hornetcorn Bio-technology Company, LTD10
暂停
1 期
Research for Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-MDS) in the Treatment of Myelodysplastic Syndrome (MDS)Myelodysplastic SyndromesNCT03184935Sclnow Biotechnology Co., Ltd.40
Unknown
不适用
Human Umbilical Cord Mesenchymal Stem Cells For the Treatment of Lumbar Disc Degeneration DiseaseLumbar Disc DegenerationLumbar Disc HerniationNCT04414592Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine20